Justification COVID-19 MCM Support.pdf

This document provides details of a limited source justification and sole source contract award. The Defense Health Agency awarded contract HT940220C0003 to an unknown vendor on September 2, 2020 for an unknown amount. The contract term is for a base period of six months with an option to extend services for an additional six months. Under the contract, senior subject matter expert consultants will provide support to the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense for their mission to develop medical countermeasures against COVID-19. Consultant expertise is required across multiple disciplines including diagnostics, vaccines, polyclonal antibodies, and small and large molecule drug development from early stages through FDA approval and post-licensure efforts. Consultants will augment internal developers to analyze, assess, design, and evaluate alternative technical approaches to accelerate the development and production of COVID-19 medical countermeasures for protection of military, coalition forces, and the nation.